Tempus and Feist-Weiller Cancer Center in an announcement by Tempus CEO and co-founder have joined hands in the fight against cancer. The partnership between the two companies will see more advanced research conducted to help fight cancer and specifically brain cancer. Tempus is a renowned technological healthcare company that boasts of a massive molecular clinic database.
Some of the services provided at the Tempus lab include genomic testing and analysis of DNA, RNA as well as proteomic data. Genome testing is quite significant when it comes to the treatment and care of cancer patients as it provides a better understanding of tumors at a molecular level. Once the physician gets the molecular analysis of a tumor, then the physician will be in a good position to diagnose the tumor and provide patients with customized treatment plans that are tailored according to their needs. Tempus besides genome testing, use other analysis methods such as lab results, radiology scans, and pathology images. All these testing methods help the doctor have a deeper understanding of the condition hence better diagnosis.
Tempus boasts of having numerous sources of clinical as well as molecular information. The data has helped Tempus physicians recommended the most effective treatment plan for their patients. With increased inventions and advanced technology such as AI, Eric Lefkofsky believes that more and more cancer patients will be able to live longer and healthier lives.
The partnership of the two firms will see Tempus organization work with Dr. Georgescu, an experienced physician in the field of glioblastoma, which is the most common type of brain tumor affecting patients. Dr. Geosgescu has been studying the tumor that is believed to be the most dangerous type of brain cancers. As a result of the partnership, Dr. Georgescu patients will be able to benefit from Tempus clinical data as well as genomic testing and data analysis for better diagnosis and therapy.
Tempus is a healthcare startup that was co-founded with Eric Lefkofsky with the aim of providing improved care and diagnosis of cancer. Lefkofsky decided to help establish Tempus after one of his relatives was diagnosed with the disease. Lefkofsky witnessed firsthand the challenges that cancer patient went through, and as a result, decided to start Tempus.